Our End-to-End Platform
At LIMAA Technologies, we develop a fully automated tissue preserving end-to-end histopathology platform for clinical use. The platform allows to analyze entire tissue biospecimens without embedding or slicing while the tissue is not consumed. The platform is a first of its kind allowing the visualization of tissue samples including downstream genomic analysis, in every routine sample - no matter what size. Due to an increase in sample volume and a general shortage of personnel in the medical field, this platform provides a simple solution for pathologists and clinicians to speed up time to diagnosis and manage ever rising sample throughput requirements. The platform enables pathologists to evaluate guideline specific multiplexed biomarker staining of tissue samples with cellular 3D spatial resolution in a clinically feasible time and to incorporate new technologies, such as artificial intelligence, on the fly.
Get in Touch for more Information
If you are interested in learning more about our team, our technology and our vision feel free to reach out to us.